Učitavanje...

Anti-tumor efficacy of oncolytic reovirus against gastrointestinal stromal tumor cells

Imatinib, a multitargeted receptor tyrosine kinase inhibitor, is used as the standard initial therapy against inoperable gastrointestinal stromal tumor (GIST). However, GIST can acquire resistance to imatinib within several years of therapy. The development of oncolytic reovirus as an anticancer age...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Inagaki, Yusuke, Kubota, Eiji, Mori, Yoshinori, Aoyama, Mineyoshi, Kataoka, Hiromi, Johnston, Randal N., Joh, Takashi
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777799/
https://ncbi.nlm.nih.gov/pubmed/29383187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23361
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!